T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
908 Devices
MASS
$293M
| $119K | ﹤0.01% |
19,385
+5,558
| +40% | +$34.8K |
|
2952
Foghorn Therapeutics
FHTX
$285M
| $118K | ﹤0.01% |
24,478
+8,070
| +49% | +$44.3K |
|
2953
SkinHealth Systems
SKIN
$94.9M
| $118K | ﹤0.01% |
131,864
+21,153
| +19% | +$26K |
|
|
SNBR
2954
DELISTED
Sleep Number
SNBR
| $118K | ﹤0.01% |
65,503
+7,300
| +13% | +$54.9K |
|
2955
Veritone
VERI
$96.7M
| $118K | ﹤0.01% |
59,674
| – | – |
|
2956
KORU Medical Systems
KRMD
$176M
| $117K | ﹤0.01% |
27,036
| – | – |
|
2957
AEye
LIDR
$52.3M
| $117K | ﹤0.01% |
64,380
| – | – |
|
2958
Protalix BioTherapeutics
PLX
$191M
| $117K | ﹤0.01% |
53,478
+18,200
| +52% | +$45.2K |
|
2959
American Well
AMWL
$181M
| $116K | ﹤0.01% |
21,998
+6,500
| +42% | +$33.4K |
|
2960
CVRx
CVRX
$126M
| $115K | ﹤0.01% |
+12,051
| New | +$88.2K |
|
2961
Viant Technology
DSP
$214M
| $115K | ﹤0.01% |
+10,241
| New | +$113K |
|
|
CD
2962
Chaince Digital Holdings
CD
$234M
| $114K | ﹤0.01% |
28,443
+10,117
| +55% | +$52K |
|
2963
Vivid Seats
SEAT
$77M
| $114K | ﹤0.01% |
19,178
| – | – |
|
|
SEVN
2964
Seven Hills Realty Trust
SEVN
$179M
| $114K | ﹤0.01% |
13,772
| – | – |
|
2965
Security National Financial
SNFCA
$247M
| $114K | ﹤0.01% |
+12,617
| New | +$108K |
|
2966
Crawford & Co Class A
CRD.A
$536M
| $113K | ﹤0.01% |
+11,283
| New | +$118K |
|
2967
Epsilon Energy
EPSN
$176M
| $113K | ﹤0.01% |
+18,300
| New | +$93.4K |
|
2968
Medallion Financial
MFIN
$226M
| $113K | ﹤0.01% |
+13,120
| New | +$129K |
|
2969
Paysign
PAYS
$486M
| $112K | ﹤0.01% |
18,928
| – | – |
|
2970
Outdoor Holding Co
POWW
$239M
| $111K | ﹤0.01% |
55,009
+9,569
| +21% | +$18.2K |
|
2971
BRC Group Holdings
RILY
$277M
| $111K | ﹤0.01% |
15,100
-4,400
| -23% | -$32.8K |
|
|
AIRO
2972
AIRO Group Holdings
AIRO
$214M
| $111K | ﹤0.01% |
+14,473
| New | +$150K |
|
2973
Byrna Technologies
BYRN
$80.3M
| $109K | ﹤0.01% |
11,814
+510
| +5% | +$6.69K |
|
2974
Xponential Fitness
XPOF
$265M
| $109K | ﹤0.01% |
17,958
| – | – |
|
2975
ZipRecruiter
ZIP
$318M
| $109K | ﹤0.01% |
58,678
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.